Stay updated on Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, effectively blocking access to the record. A minimal header with a Home link and a revision tag (Revision: v3.7.0) is shown.SummaryDifference16%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new version of the page. This appears to be a minor update to the page rather than a change to study details or results.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page shows a new revision label, updating from v3.6.4 to v3.6.5 to reflect a refreshed release of the page content. No substantive study information appears to be changed.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.6.4 was added, replacing the previous Revision: v3.6.3. This change represents a small update to the page's revision history and does not affect study information or functionality.SummaryDifference0.0%

- Check81 days agoChange DetectedRevision changed from v3.6.2 to v3.6.3, indicating a newer version of the page was published. This appears to be a minor update to the page’s revision history rather than a change to the study details.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision: v3.6.2 has been added to the page, replacing the previous Revision: v3.6.0. This indicates an updated build of the page rather than a change to substantive content.SummaryDifference0.0%

Stay in the know with updates to Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Lirentelimab in Eosinophilic Gastritis Clinical Trial page.